Cargando…

Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients

PURPOSE: Accurate delineation of intraprostatic gross tumor volume (GTV) is mandatory for successful fusion biopsy guidance and focal therapy planning of prostate cancer (PCa). Multiparametric magnetic resonance imaging (mpMRI) is the current gold standard for GTV delineation; however, prostate-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Spohn, Simon, Jaegle, Chiara, Fassbender, Thomas F., Sprave, Tanja, Gkika, Eleni, Nicolay, Nils H., Bock, Michael, Ruf, Juri, Benndorf, Matthias, Gratzke, Christian, Grosu, Anca L., Zamboglou, Constantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567709/
https://www.ncbi.nlm.nih.gov/pubmed/32342192
http://dx.doi.org/10.1007/s00259-020-04827-6
_version_ 1783596382824693760
author Spohn, Simon
Jaegle, Chiara
Fassbender, Thomas F.
Sprave, Tanja
Gkika, Eleni
Nicolay, Nils H.
Bock, Michael
Ruf, Juri
Benndorf, Matthias
Gratzke, Christian
Grosu, Anca L.
Zamboglou, Constantinos
author_facet Spohn, Simon
Jaegle, Chiara
Fassbender, Thomas F.
Sprave, Tanja
Gkika, Eleni
Nicolay, Nils H.
Bock, Michael
Ruf, Juri
Benndorf, Matthias
Gratzke, Christian
Grosu, Anca L.
Zamboglou, Constantinos
author_sort Spohn, Simon
collection PubMed
description PURPOSE: Accurate delineation of intraprostatic gross tumor volume (GTV) is mandatory for successful fusion biopsy guidance and focal therapy planning of prostate cancer (PCa). Multiparametric magnetic resonance imaging (mpMRI) is the current gold standard for GTV delineation; however, prostate-specific membrane antigen positron emission tomography (PSMA-PET) is emerging as a promising alternative. This study compares GTV delineation between mpMRI and (68)Ga-PSMA-PET in a large number of patients using validated contouring approaches. METHODS: One hundred one patients with biopsy-proven primary PCa who underwent mpMRI and (68)Ga-PSMA-PET within 3 months before primary treatment were retrospectively enrolled. Clinical parameters (age, PSA, Gleason score in biopsy) were documented. GTV based on MRI and PET images were delineated; volumes measured and laterality determined. Additionally, biopsy data from 77 patients was analyzed. Univariate and multivariate binary logistic regression analyses were performed using concordance in laterality as the endpoint. RESULTS: In total mpMRI and (68)Ga-PSMA-PET detected 151 and 159 lesions, respectively. Median GTV-MRI (2.8 ml, 95% CI 2.31–3.38 ml) was significantly (p < 0.0001) smaller than median GTV-PET (4.9 ml, 95% CI 3.9–6.6 ml). (68)Ga-PSMA-PET detected significantly more bilateral lesions than mpMRI (71 vs 57, p = 0.03). Analysis of patients with bilateral lesions in biopsy showed a significant higher concordance of laterality in (68)Ga-PSMA-PET (p = 0.03). In univariate analysis, PSA level and volume of GTV-MRI had an impact on concordance in laterality (p = 0.02 and p = 0.01), whereas in multivariate analysis, only GTV-MRI volume remained significant (p = 0.04). CONCLUSION: MpMRI and (68)Ga-PSMA-PET detect a similar amount of PCa lesions. However, GTV-PET had approximately twice the volume (median 4.9 ml vs 2.8 ml) and detected significantly more bilateral lesions than mpMRI. Thus, (68)Ga-PSMA-PET gives highly important complementary information. Since we could not find any strong evidence for parameters to guide when (68)Ga-PSMA-PET is dispensable, it should be performed additionally to MRI in patients with intermediate and high-risk PCa according to D’Amico classification to improve GTV delineation.
format Online
Article
Text
id pubmed-7567709
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-75677092020-10-19 Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients Spohn, Simon Jaegle, Chiara Fassbender, Thomas F. Sprave, Tanja Gkika, Eleni Nicolay, Nils H. Bock, Michael Ruf, Juri Benndorf, Matthias Gratzke, Christian Grosu, Anca L. Zamboglou, Constantinos Eur J Nucl Med Mol Imaging Original Article PURPOSE: Accurate delineation of intraprostatic gross tumor volume (GTV) is mandatory for successful fusion biopsy guidance and focal therapy planning of prostate cancer (PCa). Multiparametric magnetic resonance imaging (mpMRI) is the current gold standard for GTV delineation; however, prostate-specific membrane antigen positron emission tomography (PSMA-PET) is emerging as a promising alternative. This study compares GTV delineation between mpMRI and (68)Ga-PSMA-PET in a large number of patients using validated contouring approaches. METHODS: One hundred one patients with biopsy-proven primary PCa who underwent mpMRI and (68)Ga-PSMA-PET within 3 months before primary treatment were retrospectively enrolled. Clinical parameters (age, PSA, Gleason score in biopsy) were documented. GTV based on MRI and PET images were delineated; volumes measured and laterality determined. Additionally, biopsy data from 77 patients was analyzed. Univariate and multivariate binary logistic regression analyses were performed using concordance in laterality as the endpoint. RESULTS: In total mpMRI and (68)Ga-PSMA-PET detected 151 and 159 lesions, respectively. Median GTV-MRI (2.8 ml, 95% CI 2.31–3.38 ml) was significantly (p < 0.0001) smaller than median GTV-PET (4.9 ml, 95% CI 3.9–6.6 ml). (68)Ga-PSMA-PET detected significantly more bilateral lesions than mpMRI (71 vs 57, p = 0.03). Analysis of patients with bilateral lesions in biopsy showed a significant higher concordance of laterality in (68)Ga-PSMA-PET (p = 0.03). In univariate analysis, PSA level and volume of GTV-MRI had an impact on concordance in laterality (p = 0.02 and p = 0.01), whereas in multivariate analysis, only GTV-MRI volume remained significant (p = 0.04). CONCLUSION: MpMRI and (68)Ga-PSMA-PET detect a similar amount of PCa lesions. However, GTV-PET had approximately twice the volume (median 4.9 ml vs 2.8 ml) and detected significantly more bilateral lesions than mpMRI. Thus, (68)Ga-PSMA-PET gives highly important complementary information. Since we could not find any strong evidence for parameters to guide when (68)Ga-PSMA-PET is dispensable, it should be performed additionally to MRI in patients with intermediate and high-risk PCa according to D’Amico classification to improve GTV delineation. Springer Berlin Heidelberg 2020-04-28 2020 /pmc/articles/PMC7567709/ /pubmed/32342192 http://dx.doi.org/10.1007/s00259-020-04827-6 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Spohn, Simon
Jaegle, Chiara
Fassbender, Thomas F.
Sprave, Tanja
Gkika, Eleni
Nicolay, Nils H.
Bock, Michael
Ruf, Juri
Benndorf, Matthias
Gratzke, Christian
Grosu, Anca L.
Zamboglou, Constantinos
Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
title Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
title_full Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
title_fullStr Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
title_full_unstemmed Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
title_short Intraindividual comparison between (68)Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
title_sort intraindividual comparison between (68)ga-psma-pet/ct and mpmri for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567709/
https://www.ncbi.nlm.nih.gov/pubmed/32342192
http://dx.doi.org/10.1007/s00259-020-04827-6
work_keys_str_mv AT spohnsimon intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT jaeglechiara intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT fassbenderthomasf intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT spravetanja intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT gkikaeleni intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT nicolaynilsh intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT bockmichael intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT rufjuri intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT benndorfmatthias intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT gratzkechristian intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT grosuancal intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients
AT zamboglouconstantinos intraindividualcomparisonbetween68gapsmapetctandmpmriforintraprostatictumordelineationinpatientswithprimaryprostatecanceraretrospectiveanalysisin101patients